Related references
Note: Only part of the references are listed.Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines?
Jane L. Yen-Revollo et al.
CLINICAL CANCER RESEARCH (2008)
Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review
M. W. Saif et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2008)
An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer
J. Sakamoto et al.
BRITISH JOURNAL OF CANCER (2007)
Estimates of the cancer incidence and mortality in Europe in 2006
J. Ferlay et al.
ANNALS OF ONCOLOGY (2007)
Patient preference for oral or intravenous chemotherapy: A randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancer
P. Pfeiffer et al.
EUROPEAN JOURNAL OF CANCER (2006)
Chemotherapy with preoperative radiotherapy in rectal cancer
Jean-Francois Bosset et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144
Stephen R. Smalley et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: A multicenter randomized controlled trial
Takayuki Akasu et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2006)
The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?
R Glynne-Jones et al.
ANNALS OF ONCOLOGY (2006)
Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer
LW Wang et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
Practice parameters for the management of rectal cancer (revised)
JJ Tjandra et al.
DISEASES OF THE COLON & RECTUM (2005)
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of rectal cancer
KM Tveit et al.
ANNALS OF ONCOLOGY (2005)
Phase I study of UFT plus leucovorin with radiotherapy in patients with inextirpable non-rectal, gastrointestinal cancer
P Byström et al.
RADIOTHERAPY AND ONCOLOGY (2004)
Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: Joint United States and Japan study of UFT/LV
K Shirao et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer:: A phase II multicenter study with 3 years' follow-up
C Fernández-Martos et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Preoperative versus postoperative chemoradiotherapy for rectal cancer
R Sauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients
MJ Millward et al.
ANNALS OF ONCOLOGY (2003)
Phase I study of oral uracil and Tegafur plus leucovorin and pelvic radiation in patients with recurrent rectal cancer
ME Schiebe et al.
ANTI-CANCER DRUGS (2002)
Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer
JY Douillard et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer
J Carmichael et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy
J Feliu et al.
ANNALS OF ONCOLOGY (2002)
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PV1 5-FU) with epirubicin, cisplatin, and PV15-FU in advanced esophagogastric cancer
P Ross et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
First-line oral capecitabine therapy in metastatic colorectal cancer:: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
J Cassidy et al.
ANNALS OF ONCOLOGY (2002)
Radiosensitization by oxaliplatin in a mouse adenocarcinoma: Influence of treatment schedule
A Cividalli et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin:: a randomised crossover trial in advanced colorectal cancer
MM Borner et al.
EUROPEAN JOURNAL OF CANCER (2002)
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02
N Wolmark et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
